U.S. Non-Invasive Prenatal Testing Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)

Report ID: 49768 | Published Date: Sep 2024 | No. of Page: 130 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
1. Executive Summary

2. United States Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2015 - 2027)
2.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
2.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast

3. United States Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2015 - 2027) 
3.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
3.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast

4. United States Actual Non–Invasive Prenatal Testing Market Size and Forecast (2015 - 2027) 
4.1 Average Risk Actual NIPT Test Market Size and Forecast
4.2 High-Risk Actual NIPT Test Market Size and Forecast

5. United States Potential Non–Invasive Prenatal Testing Market Size and Forecast (2015 - 2027) 
5.1 Average Risk Potential NIPT Test Market Size and Forecast
5.2 High-Risk Potential NIPT Test Market Size and Forecast

6. United States Non–Invasive Prenatal Testing Market Drivers and Inhibitors
6.1 Key Market Drivers
6.2 Key Market Inhibitors

7. Non–Invasive Prenatal Testing Comparative Analysis

8. Reimbursement Environment of the United States Non-Invasive Prenatal Testing

9. Regulation Framework of the United States Non-Invasive Prenatal Testing

10. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
10.1 Collaboration Deals
10.2 Venture Capital Investment
10.3 Merger and Acquisition
10.4 Exclusive Agreement
10.5 Licensing Agreement
10.6 Distribution Agreement
10.7 Partnership Deals

11. Key Companies Analysis
11.1 Integrated Genetics (LabCorp) 
11.1.1 Business Overview
11.1.2 Product Outlook
11.1.3 Key Developments
11.2 Yourgene Health
11.2.1 Business Overview
11.2.2 Product Outlook
11.2.3 Key Developments
11.3 Ariosa Diagnostics (Roche) 
11.3.1 Business Overview
11.3.2 Product Outlook
11.3.3 Key Developments
11.4 Illumina
11.4.1 Business Overview
11.4.2 Product Outlook
11.4.3 Key Developments
11.5 Natera
11.5.1 Business Overview
11.5.2 Product Outlook
11.5.3 Key Developments
11.6 Quest Diagnostics
11.6.1 Business Overview
11.6.2 Product Outlook
11.6.3 Key Developments
11.7 Myriad Genetics
11.7.1 Business Overview
11.7.2 Product Outlook
11.7.3 Key Developments
11.8 Centogene
11.8.1 Business Overview
11.8.2 Product Outlook
11.8.3 Key Developments
11.9 Invitae Corporation
11.9.1 Business Overview
11.9.2 Product Outlook
11.9.3 Key Developments
11.10 GenPath
11.10.1 Business Overview
11.10.2 Product Outlook
11.10.3 Key Developments
11.11 Progenity
9.11.1 Business Overview
11.11.1 Product Outlook
11.11.2 Key Developments
11.12 PerkinElmer
11.12.1 Business Overview
11.12.2 Product Outlook
11.12.3 Key Developments
11.13 Agilent Technologies
11.13.1 Business Overview
11.13.2 Product Outlook
11.13.3 Key Developments
List of Tables

Table 6–1: Maternal Age at Delivery and Risk of Down Syndrome
Table 7–1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 10–1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
Table 10–2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
Table 10–3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
Table 10–4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
Table 10–5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
Table 10–6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
Table 10–7: Partnership Deals in the Non–Invasive Prenatal Testing Market


List of Figures

Figure 2–1: United States Actual NIPT Test Volume (Thousand),2015 – 2019
Figure 2–2: United States Actual NIPT Test Volume Forecast (Thousand),2020 – 2027
Figure 2–3: United States Average Risk Actual NIPT Test Volume (Thousand),2015 – 2019
Figure 2–4: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2020 – 2027
Figure 2–5: United States High-Risk Actual NIPT Test Volume (Thousand),2015 – 2019
Figure 2–6: United States High-Risk Actual NIPT Test Volume Forecast (Thousand),2020 – 2027
Figure 3–1: United States Potential NIPT Test Volume (Thousand),2015 – 2019
Figure 3–2: United States Potential NIPT Test Volume Forecast (Thousand),2020 – 2027
Figure 3–3: United States Average Risk Potential NIPT Test Volume (Thousand),2015 – 2019
Figure 3–4: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2020 – 2027
Figure 3–5: United States High-Risk Potential NIPT Test Volume (Thousand),2015 – 2019
Figure 3–6: United States High-Risk Potential NIPT Test Volume Forecast (Thousand),2020 – 2027
Figure 4–1: United States Actual NIPT Test Market Size (Million US$),2015 – 2019
Figure 4–2: United States Actual NIPT Test Market Size Forecast (Million US$),2020 – 2027
Figure 4–3: United States Average Risk Actual NIPT Test Market Size (Million US$),2015 – 2019
Figure 4–4: United States Average Risk Actual NIPT Test Market Size Forecast (Million US$),2020 – 2027
Figure 4–5: United States High-Risk Actual NIPT Test Market Size (Million US$),2015 – 2019
Figure 4–6: United States High-Risk Actual NIPT Test Market Size Forecast (Million US$),2020 – 2027
Figure 5–1: United States Potential NIPT Test Market Size (Million US$),2015 – 2019
Figure 5–2: United States Potential NIPT Test Market Revenue Forecast (Million US$),2020 – 2027
Figure 5–3: United States Average Risk Potential NIPT Test Market Size (Million US$),2015 – 2019
Figure 5–4: United States Average Risk Potential NIPT Test Market Revenue Forecast (Million US$),2020 – 2027
Figure 5–5: United States High-Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2019
Figure 5–6: United States High-Risk Potential NIPT Test Market Revenue Forecast (Million US$),2020 – 2027
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
U.S. Non-Invasive Prenatal Testing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
U.S. Non-Invasive Prenatal Testing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
U.S. Non-Invasive Prenatal Testing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports